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Oxidative stress appears to play a role in the pathogenesis of  several infl ammatory 
gastrointestinal diseases. Increased homocysteine levels may play a role in the 
pathogenesis of  Chron’s disease and ulcerative colitis. The aim of  this study was to 
examine the infl uence of  homocysteine on the antioxidant status of  rat intestine and 
liver. The levels of  thiobarbituric acid reactive substances (TBARS), activity of  catalase 
(CAT) and total antioxidant status (TAS) were investigated in the isolated gut and liver 
of  young male rats in the control group (8 rats) and after 3-hоur incubation in high 
doses of  D, L-homocysteine thionolactone (Hcy) (10 μmol/L) (8 rats). Samples of  
duodenum, ileum, colon and liver were homogenized in sodium phosphate buffer 
(1:10). Homogenates were centrifuged at 10000 for 10 min at 40 C and the supernatant 
was taken for biochemical assays. Our results showed that high D, L-homocysteine 
thionolactone concentration reduced enzymatic catalase activity in homogenates of  
the isolated segments of  duodenum (27.04%) p<0.01; ileum (37.27%), colon (34.17%) 
and liver (67.46%) p<0.001. Exposition to high D,L-homocysteine thiolactone 
concentration signifi cantly increased TBARS levels in the duodenum (106.05%), ileum 
(47.24%), colon (112.75%) and liver (32.07%) (p<0.01). Homocysteine also modifi ed 
the total antioxidant status of  homogenates from the duodenum, ileum, colon and liver, 
increasing by 20.68% (duodenum), 24.74% (ileum), 14.88% (colon) and 19.35% (liver) 
(p<0.001). Homocysteine induced a consistent oxidative stress in rat’s intestine and liver 
(reduced activity of  catalase and increased level of  TBARS), but the elevated activity of  
TAS in our experiments could be explained as an adaptive response to the generated 
free radicals which indicates the failure of  the total antioxidant defense mechanism to 
protect the tissues from damage caused by homocysteine.
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INTRODUCTION
Oxidative stress due to the production of   intracellular and extracellular reactive oxygen 
species may be a major player in the pathogenesis of  cardiovascular and other diseases. 
It is now well established that hyperhomocysteinemia is an independent risk factor for 
coronary artery diseases, cerebrovascular diseases, and peripheral vascular occlusive 
diseases. Tissue accumulation of  homocysteine (Hcy) occurs in homocystinuria, 
a metabolic disease characterized by defi ciency of  cystathionine b-synthase and by 
mental retardation, vascular problems, skeletal abnormalities, and hepatic compromise, 
with fatty accumulation and cirrhosis [1]. 
Oxidative stress appears to play a role in the pathogenesis of  several infl ammatory 
gastrointestinal diseases [2,3]. Changes in intestinal motility have been reported in 
different models of  intestinal infl ammation. The initiating factor of  altered motility 
could be an alteration of  gut redox status. Increased homocysteine levels in the colonic 
mucosa and plasma of  patients with infl ammatory bowel disease (IBD) may play a 
role in the pathogenesis of  Chron’s disease and ulcerative colitis. Homocysteine is also 
known to aggravate the pathogenesis of  IBD. Interestingly, the colon is the pivot site 
that regulates Hcy levels in the plasma.
Milton et al. [4] showed that homocysteine inhibited hydrogen peroxide breakdown 
by catalase (CAT) in the human neuroblastoma cell line. Matte et al. [5] showed that 
homocysteine induced oxidative stress in rat liver. Streck et al. [6] demonstrated that 
homocysteine signifi cantly increased thiobarbituric acid-reactive substances (TBARS), 
but did not change antioxidant enzymes. Their results suggest that oxidative stress is 
involved in the neurological dysfunction of  homocystinuria in the rat hippocampus.
Catalase, an antioxidant enzyme responsible for the degradation of  hydrogen peroxide, 
is protective in many diseases. The amino-acid homocysteine has been suggested to 
be a pro-oxidant with elevated levels linked to the oxidative stress seen in Alzheimer’s 
and other diseases. This study shows that homocysteine inhibits the breakdown of  
hydrogen peroxide [7].
The aim of  this study was to examine the infl uence of  high level of  homocysteine 
on the antioxidant status of  rat intestine tissue (duodenum, ileum, colon) and liver. In 
the present study, the effects of  acute administration of  homocysteine thionolactone 
(metabolite of  homocysteine) on the formation of  TBARS, total antioxidant status 
(TAS) and CAT activity were investigated.
MATERIAL AND METHODS
Wistar rats were obtained from the Central Animal House Department of  the Institute 
of  Physiology, University of  Belgrade. Animals were treated according to the Guide 
for the Care and Use of  Small Laboratory Animals, School of  Medicine, University of  
Belgrade, License number 5287/2.
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 The investigation conforms to the regulations of  the European Union and USA Guide 
for Care and Use of  Laboratory Animals published by the US National Institutes of  
Health, NiH publication No. 85-23, revised 1985. 
All chemicals were obtained from Sigma Chemical Co., St. Louis, MO, USA. Rats, 
aged 20-21 weeks and weighing 160±200 g were anesthetized with ketamine 4mg/kg 
body mass. After cervical dislocation the gastrointestinal tract and liver were quickly 
removed and processed as follows. Group I (control, n=8) (duodenum, ileum, colon) 
and liver were kept in Tyrode’s solution, group II (experimental, n=8) were in Tyrode’s 
solution with homocysteine (10 μmol/L). Both groups were incubated for three hours. 
After completion of  the treatment period, the tissues were homogenized in 10 ml 
(1:10) of  50 mM sodium phosphate buffer, pH 7.0. Homogenates were centrifuged at 
13000 for 10 min. at 40 C to discard nuclei and cell debris. The supernatant was taken 
for biochemical assays. The homogenates used were from individual animals and they 
were not pooled. 
Protein contents were measured according to the method of  Bratford [8] using bovine 
serum albumin as standard. 
Catalase assay
Catalase (Cat) activity was determined based on the spectrophotometric measurement 
according to Aebi [9]. This method was based on the disappearance of  H2O2 at 240 nm 
in the reaction medium containing 30 mM H2O2, 50 mmol/L potassium phosphate 
buffer pH 7.0 and 0.1 ml sample Cat activity expressed as micromoles of  hydrogen 
peroxide decomposed /min /mg protein. 
Lipid peroxidation
Lipid peroxidation (LPO) was measured in tissue homogenates according to the method 
of  Ohkawa et al. [10]. Briefl y, 25 μl homogenates, 975 μl TRIS buffer pH 7.0 and 2 ml 
TBA reagent were added into glass tubes. The mixture was vortexed and reaction was 
carried out in a boiling water bath for 1 h. The mixture was allowed to cool in water 
for 5 min. and was centrifuged at 750 x g for 10 min at 250 C. The obtained resulting 
pink stained TBARS were determined at 535 nm (ULTROSPECT 2000, Pharmacia 
biotech). The measurement was based on the formation of  thiobarbituric acid-reactive 
substances (TBARS) and expressed as the extent of  MDA production. TBARS were 
calculated as μmol TBARS /mg protein.
Tissue total antioxidant status (TAS)
TAS was measured on Ultrospect 2000 Analyzer with Randox reagent set (Randox). 
The determination was based on the reaction of  2,2,-azino-di-(3-ethylbenythiazoline 
sulfonate) (ABTS+) with peroxidase (metmyoglobin) and H2O2 to produce the 
radical cation ABTS+ [11]. For the total antioxidant assay, 2,2-azinobis-(3-ethyl-
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benzothiazoline-6-sulfonic acid) (Sigma–Aldrich) was dissolved in deionized water to 
a 7 mM concentration.
The ABTS radical cation (ABTS+) was produced by reacting the ABTS stock solution 
with  2.45 mM potassium persulfate (fi nal concentration) and incubating the solution 
in the dark at room temperature for 12–16 h before use. The radical stock solution 
was diluted with a 5 mM solution of  phosphate-buffered saline (PBS; pH 7.4) to 
obtain a spectrophotometric absorbance value of  0.700 ± 0.020 at 734 nm. Trolox 
(a Vitamin E analogue) standards (Calbiochem) were prepared in PBS over the range 
0–15 μM. For the standardization of  the starting point of  all assays and standards, a 
10 μl sample/Trolox standard was added to 1 ml ABTS ± solution (A734 nm=0.700± 
0.020) and an absorbance reading taken exactly 1 min after initial mixing until the 
decrease in absorbance ceased. Assays were performed in triplicate and validations 
were performed against PBS to confi rm that extraction buffer components did not 
interfere with the analysis.
The antioxidant activity was expressed as the rate of  decrease in absorbance (min/mg 
protein) and as the mean of  three replicate samples.
Statistical analysis
Results were analyzed by standard statistical methods, expressed as mean ± SD and 
graphically presented (Statistical program GraphPad Prism 6). Signifi cance of  the 
differences between the experimental and control groups was determined by Student’s 
t-test. Differences were considered signifi cant at p< 0.05. 
RESULTS
Catalase activity, TBARS and TAS in isolated segments of duodenum, ileum, 
colon and liver incubated in Tyrode,,s solution during 3 hours
The summary of  the main characteristics of  control values of  oxidative stress parameters 
(catalase activity, TBARS and TAS concentration) are  presented  in  Table I.
Catalase activity showed the highest value in the liver (347.63 ± 60.11 U/mg protein), the 
lowest value in the duodenum (166.50 ± 10.44 U/mg protein). There was a statistically 
signifi cant difference between values in liver and other organs of  gastrointestinal tract. 
Also the differences were found between other organs: duodenum –D; ileum –I, colon 
-C  were signifi cant (D/I p<0.01; D/C p<0.01; D/L p<0.05; I/C not signifi cant ; I/L 
p<0.01, C/L p<0.05).
TBARS concentration was the highest in the liver (2.43 ± 0.1 μmol/mg protein), the 
lowest in duodenum (0.92 ± 0.23 μmol/mg protein). There was a statistically signifi cant 
difference between control values in the liver and other examined organs ((P< 0.001), 
but the difference between the duodenum, ileum and colon were not signifi cant (D/I 
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not signifi cant; D/C not signifi cant; D/L p<0,001; I/C not signifi cant; I/L p<0,001, 
C/L p<0,001).
TAS values were the highest the duodenum (7.24 ± 0.45(mmol Trolox/mg protein), 
statistically signifi cantly higher compared to the ileum, colon and liver. D/I p<0.05; 
D/C p<0.05; D/L p<0.05.  There were no signifi cant differences between the values 
in the other three organs (I/C not signifi cant; I/L not signifi cant, C/L  not signifi cant).
Table 1. Oxidative stress parameters in the duodenum, ileum, colon and liver of  control rats 
(group I) and rats treated with D,L homocysteine thiolactone (group II)
Catalase
(U/mg protein)
TBARS
(μmol/mg protein)
TAS
(mmol Trolox/mg 
protein)
Group I Group II Group I Group II Group I Group II
Duodenum 166.50±10.44 121.45±4.88**
↓ 27.04%
0.92±0.23 2.23±0.28**
↑ 106.05%
7.24±0.45* 8.73±0.64***
↑ 20.68%
Ileum 291.99±14.92 203.50±31.12***
↓ 37.27%
1.098±0.10 1.62±0.10**
↑ 47.24%
5.39±0.28 6.73±0.20***
↑ 24.74%
Colon 232.11±14.92 152.79±15.11***
↓ 34.17%
1.10±0.14 2.34±0.24**
↑ 112.75 %
5.87±0.14 6.74±0.09***
↑ 14.88%
Liver 347.63±60.11* 113.13±10.77***
↓ 67.46%
2.43±0.18*** 3.21±0.29**
↑ 32.07%
5.34±0.41 6.27±0.42***
↑ 19.35%
Data are presented as mean ± SE; n=8 (in the group II % of  changes compared to control value; 
*p<0.05, **p<0.01, ***p<0.001).
Catalase activity, TBARS and TAS in isolated segments of duodenum, ileum, 
colon and liver incubated in homocysteine (10 μmol/L) during 3 hours
Incubation in D,L- homocysteine thionolactone during 3 hours showed a signifi cant 
infl uence on antioxidant defenses and lipid peroxidation in all examined organs Table I.
CAT activity was reduced in all investigated organs, maximum decrease was observed 
in the ileum and liver. In absolute values the highest activity of  catalase was observed 
in the ileum (203,502 U/mg protein) and the lowest in the liver (113.13 U/mg protein). 
In Fig. 1 are presented control values and the reduction of  catalase activity after 
incubation in D,L homocysteine thionolactone (it varied from 27.04 % in duodenum 
to 67.6% in liver). All the values were signifi cantly different compared to the control 
group p<0.01, but the differences between the organs were signifi cant too: (D/I 
p<0,05; D/C not signifi cant; D/L not signifi cant; I/C not signifi cant; I/L p<0,05, 
C/L not signifi cant).
In Fig F.2 are presented the levels of  TBARS.  The highest level of  TBARS was observed 
in the liver (3.21 μmol/mg protein, while in the ileum was the lowest (1.62 μmol/
mg protein). Highest increase compared to the control group was observed in colon 
(112.76%), the lowest in liver (32.07%). All the values were signifi cantly different 
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compared to control group (D/I not signifi cant; D/C not signifi cant; D/L p<0.05; 
I/C p<0.05; I/L p<0.001; C/L p<0.05). 
In Fig.3 are presented the levels of  TAS. Increased levels varied with highest level 
observed in duodenum (8.73 ± 0.64 mmol Trolox/mg protein, the lowest in the liver 
(6.27 mmol Trolox/mg protein). The increase varied from 14.88% in the colon to 
24.74% in the ileum. All the values are signifi cantly different compared to the control 
group (D/I p<0.05; D/C p<0.05; D/L p<0.05; I/C not signifi cant; I/L not signifi cant, 
C/L not signifi cant).
DISCUSSION
In the present study, the effects of  acute administration of  D,L-homocysteine 
thiolactone on non-enzymatic and enzymatic antioxidant defenses were investigated 
in an in vitro animal model of  rat duodenum, ileum, colon and liver. 
Figure 1. Catalase activity in the duodenum, ileum, colon and liver of  control rats (group 
I) and rats treated with D,L-homocysteine thiolactone (group II) . Results are expressed as 
mean ± SD for 8 animals in each group. Different from the controls, **p<0.01; ***p<0.001 
(Student’s t-test). Hcy (homocysteine)
Figure 2. TBARS concentration in the duodenum, ileum, colon and liver of  control rats 
(group I) and rats treated with D,L-homocysteine thiolactone (group II) . Results are expressed 
as mean ± SD for 8 animals in each group. Different from the controls, **p<0.01 (Student’s 
t-test). Hcy (homocysteine)
Figure 3. Total antioxidant status in the duodenum, ileum, colon and liver of  control rats 
(group I) and rats treated with D,L-homocysteine thiolactone (group II) .  Results are expressed 
as mean ± SD for 8 animals in each group. Different from the controls, ***p<0.001 (Student’s 
t-test). Hcy (homocysteine)
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Incubation of  tissues in high D,L-homocysteine thiolactone concentration reduced 
enzymatic CAT activity in the duodenum,  ileum, colon  and liver  compared to the 
control group. A signifi cant inhibition of  hepatic CAT activity and intestinal CAT 
activity in rat organs incubated in homocysteine was also verifi ed in literature [12,13]. 
Other studies suggested a negative correlation between plasma Hcy levels and CAT 
activity in the liver of  rats, indicating a signifi cant reduction of  hepatic antioxidant 
defense [13,14]. We observed a signifi cant inhibition of  hepatic CAT activity in 
hyperhomocysteinemic rats. In agreement with our data, other studies suggest a 
negative correlation between plasma Hcy levels and CAT activity in the liver of  rats, 
pointing a signifi cant reduction of  hepatic antioxidant defense [15,16]. The results 
from this study show that homocysteine can act directly on catalase and inhibit the 
breakdown of  H2O2. The suggestion that homocysteine can itself  generate H2O2, with 
the assistance of  copper, has provided a proposed mechanism for this contribution. 
Exposition to high D,L-homocysteine thiolactone concentrations signifi cantly 
increased TBARS levels in the duodenum, ileum, colon  and liver. Kolling et al. [17] 
showed that Hcy increased lipid peroxidation and TBARS level in rats’ heart. Lipid 
peroxidation was also observed in the liver of  rats, and was associated with Hcy-
induced cell injury, including  apoptosis and infl ammation in liver disease [12,13]. 
Hepatic lipid peroxidation appears to be strongly associated with Hcy levels [18]. 
Similar results reported Matte et al. [5]. They showed the occurrence of  oxidative 
stress and notably reduced antioxidant defenses (enzymatic and non-enzymatic) and 
increased lipid peroxidation, and infl ammatory infi ltration in the liver of  Hcy-treated 
rats. 
TAS is a more useful index of  antioxidant status because it considers not only the 
quantity, but also the reactivity of  antioxidants. Our results showed that Hcy increased 
the total antioxidant status of  homogenates from the duodenum, ileum, colon and 
liver suggesting that this amino acid causes the acute increase of  quantity of  non-
enzymatic antioxidants in the liver and intestine. 
The elevated activity of  TAS is due to the adaptive response to generated free radicals, 
indicating the failure of  the total antioxidant defense mechanism to protect the tissues 
from mechanical damage caused by homocysteine, as evidenced by lipid peroxidation. 
According to our fi ndings, homocysteine, during exposition, directly inhibited catalase 
activity, activated the process of  lipid peroxidation and elevated total antioxidant status 
in the isolated intestine and liver. The observed increase in lipid peroxidation and TAS 
suggests the presence of  oxidative stress in the gastrointestinal system.
A correlation between oxidative stress and high levels of  homocysteine has 
been demonstrated in vascular smooth muscle cells [19]. Homocysteine inhibits 
endothelium-dependent NO-mediated dilation in the porcine retinal arterioles by 
producing superoxide from NAD(P)H oxidase [20].
Although the present study only concerns the acute effects of  Hcy on oxidative stress 
parameters in rats, it is tempting to consider the reported prooxidant effects of  Hcy 
on the gastrointestinal system in animals and humans. It is proposed that chronic 
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oxidative stress contributes to the pathogenesis of  some infl ammatory digestive 
diseases. Reactive oxygen species (ROS) are produced within the gastrointestinal 
(GI) tract, but their roles in the pathophysiology and disease pathogenesis have not 
been well studied. Elevated levels of  plasma homocysteine have been implicated in 
infl ammation and remodeling of  the intestinal vasculature, and Hcy is also known to 
aggravate the pathogenesis of  infl ammatory bowel disease (IBD), Chron’s, disease, 
ulcerative colitis, etc. Interestingly, the colon is the pivot site that regulates Hcy levels 
in the plasma. Levels of  ROS, superoxide, and inducible nitric oxide were elevated 
in hyperhomocysteinemia. A large number of  literature data indicates that oxidative 
stress correlates with the level of  homocysteine in diseases of  the digestive tract [21]. 
Early identifi cation of  hyperhomocysteinemia and markers of  oxidative stress may 
reduce the progression of  some gastrointestinal diseases and their complications such 
as infl ammatory bowel disease, Crohn’s disease, ulcerative colitis and susceptibility to 
thrombotic events [21]. 
Low erythrocyte catalase enzyme activity was found to correlate with high serum 
total homocysteine levels in Tunisian patients with acute myocardial infarction. 
Hyperhomocysteinemia may increase the myocardial wall dysfunction by excessive 
production of  reactive oxygen species which is made evident by increased lipid 
peroxidation [22-24].
During chronic exposition to high levels of  homocysteine, the patients with diabetes 
mellitus, cardiovascular disease and gastrointestinal disease, obesity and metabolic 
syndrome showed decreased levels of  TAS [25]. 
The signifi cant correlation between oxidative stress markers levels and Hcy levels was 
found in the study by Nanetti et al [26]. They suggested that Hcy levels control could 
positively interact with some of  the pathological changes involved in the evolution of  
cerebral ischemic damage.  Milton [4] showed that homocysteine inhibited hydrogen 
peroxide breakdown by catalase in human neuroblastoma cell line.
Oxidative damage is involved in the pathogenesis of  primary open angle glaucoma and 
homocysteine has a role in the development of  this type of  glaucoma [27]. It has been 
reported that elevated homocysteine (Hcy) may activate oxidative stress and reduce 
bone mineral density in post-menopausal osteoporosis [28].
The pathogenesis of  various GI diseases including peptic ulcers, gastrointestinal 
cancers, and infl ammatory bowel disease is in part due to oxidative stress [2,3].
Unraveling the signaling events initiated at the cellular level by oxidative free radicals 
as well as the physiological responses to such stress are important to better understand 
disease pathogenesis and to develop new therapies.
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EFEKTI AKUTNE ADMINISTRACIJE D,L-HOMOCISTEIN 
TIOLAKTONA NA ANTIOKSIDATIVNI STATUS CREVA I JETRE 
PACOVA
STOJANOVIĆ Marija, ŠĆEPANOVIĆ Ljiljana, BOSNIĆ Olivera, MITROVIĆ 
Dušan, JOZANOV-STANKOV Olga, ŠĆEPANOVIĆ Vuk, ŠĆEPANOVIĆ Radomir, 
STOJANOVIĆ Teja, ILIĆ Slobodan, DJURIĆ Dragan
Oksidativni stress igra ulogu u patogenezi brojnih gastrointestinalnih infl amatornih 
obolenja. Povišen nivo homocisteina može imati ulogu u patogenezi Kronove bolesti 
i ulceroznog kolitisa. Cilj ovog rada je da ispita uticaj homocisteina na antioksidativni 
status u tkivu creva i jetre pacova. U crevu i jetri pacova muškog pola praćeni su nivoi 
reaktivnih supstanci tiobarbiturne kiseline (TBARS), aktivnost katalaze (CAT), i totalni 
antioksidativni status (TAS) u kontrolnoj grupi (8 pacova) i posle tročasovne inkubacije 
u D,L-homocistein tiolaktonu (10μmol/L) (8 pacova). Uzorci tkiva duodenuma, 
ileuma, kolona i jetre su homogenizovana u fosfatnom puferu (1:10). Homogenati 
su centrifugirani na 10000 obrtaja 10 min na 40 C i supernatanti su korišćeni za 
biohemijske analize. Naši rezultati su pokazali da visoka koncentracija D,L-homocistein 
tiolaktona smanjuje aktivnost katalaze u homogenatima izolovanih segmenata 
duodenuma (27.04%) p<0.01; ileuma (37, 27%), kolona (34, 17%) i jetre (67, 46%) 
p<0.001. Izlaganje visokim koncentracijama D,L- homocistein tiolaktona značajno 
povećava nivo TBARS u duodenumu (106.05%), ileumu (47.24%), kolonu (112.75%) 
i jetri (32.07%) (p<0.01). Homocistein takođe modifi kuje totalni antioksidativni 
status u homogenatima duodenuma, ileuma, kolona i jetre, povećavajući ga za 20.68% 
(duodenum), 24.74% (ileum), 14.88% (kolon) i 19.35% (jetra) (p<0.001). Homocistein 
dovodi do oksidativnog stresa u tkivu creva i jetre pacova (smanjena aktivnost katalaze 
i povećan nivo TBARS), a povišena aktivnost TAS-a u našem eksperimentu se može 
objasniti kao adaptivni odgovor na stvaranje slobodnih radikala i pokazuje na neuspeh 
ukupnog mehanizma antioksidativne odbrane u zaštiti tkiva od oštećenja izazvanih 
homocisteinom. 
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